Erythema multiforme
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Erythema multiforme minor ― Nota quod centra laesiones albas esse possunt.
Urticaria etiam considerari potest ut diagnosis differentialis.
References
Erythema multiforme (EM) Conditio est ubi maculae propriae scopo-similes apparent in utraque cute et membranae mucosae ob motus immunes. Etsi saepe contagio virales utitur, praesertim herpes simplex virus (HSV) , vel quaedam medicamenta, causa in multis casibus ignota manet. Acutum EM tractans intendit ad levationem symptomata utens crepitu steroids vel antihistamines continens. Administrandi frequentissima EM efficacissima est, cum unicuique patienti formanda est. Primae aditus involvunt curationes orales tum topicas. Haec includunt corticosteroides et medicamenta antiviralia. General treatments constant fortibus cremoribus steroidalibus et solutionibus pro membranis mucosis affectis. Aegris male gratus ad antivirales, secundae lineae optiones includit medicamenta immunia suppressa, antibiotica, anthelmintica et antimalaria.
Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials
Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials
Multis in rebus, mitis erythema multiforme abit sua sponte intra 2 ad 4 septimanas. Stevens-Johnson syndrome, gravis condicio membranis mucosis afficiens, usque ad 6 septimanas durare potest. Steroids non sunt typice commendantur pro casibus lenibus. Utrum steroids adhibeantur ad erythema multiformi gravi, incertum est, cum nullae sint claris inventis ex studiis incertis adhibitis, quibus pueri hac curatione prodessent.
In most cases, mild erythema multiforme is self-limited and resolves in 2 to 4 weeks. Stevens-Johnson syndrome is a serious disease that involves the mucous membranes and lasts up to 6 weeks. There is no indication for using steroids for the mild form. Use of steroids for erythema multiforme major is debatable because no randomized studies clearly indicate which children will benefit from this treatment.
In most cases, mild erythema multiforme is self-limited and resolves in 2 to 4 weeks. Stevens-Johnson syndrome is a serious disease that involves the mucous membranes and lasts up to 6 weeks. There is no indication for using steroids for the mild form. Use of steroids for erythema multiforme major is debatable because no randomized studies clearly indicate which children will benefit from this treatment.
Casum oralis erythema multiforme (EM) ex TMP/SMX causatum exhibemus, ostendens ulcera typica oris et labii sine laesionibus cutis. Hoc sapienter opus est distinguere ab aliis morbis ulcerativis oris oralis. Aegrotus curatio symptomatica et tabulas prednisolones accepit, ducens ad emendationem cum curatione TMP/SMX.
We report a case of oral erythema multiforme (EM) secondary to TMP/SMX that presented with oral and lip ulcerations typical of EM without any skin lesions and highlights the importance of distinguishing them from other ulcerative disorders involving oral cavity. The patient was treated symptomatically and given tablet prednisolone. The condition improved with stoppage of TMP/SMX therapy.
We report a case of oral erythema multiforme (EM) secondary to TMP/SMX that presented with oral and lip ulcerations typical of EM without any skin lesions and highlights the importance of distinguishing them from other ulcerative disorders involving oral cavity. The patient was treated symptomatically and given tablet prednisolone. The condition improved with stoppage of TMP/SMX therapy.
Erythema multiforme Reactio est quae cutem implicat et interdum mucosa, quae systemate immune utitur. De more manifestat laesiones clypeo-similes, quae separatim apparent, recurrunt, vel perseverant. Hae laesiones aequaliter extremas, praecipue exteriores superficies, afficiunt. Causae principales includunt infectiones sicut herpes, virus simplex et Mycoplasma pneumoniae, ac quaedam medicamenta, immunizationes, et morbi autoimmune. Distinguendi erythema multiforme ab urticaria duratione laesiones nititur; erythema multiforme Laesiones per septem saltem dies fixa manent, dum laesiones urticariae intra diem saepe evanescunt. Tametsi similis, pendet ad differentiam erythema multiforme a syndrome graviore Stevens-Johnson, quae typice exhibet erythematosam vel purpuricam maculam cum pusulis diffusa. Administrandi erythema multiforme subsidia symptomatica cum steroidibus topicis vel antihistaminis implicat et causa subiecta alloquitur. Pro casibus recurrentibus coniungendis cum herpes virus simplici, therapia prophylactica antiviralis commendatur. Gravis implicatio mucosalis potest hospitalizationem postulare pro humoribus intravenosis et postea electrolytici.
Erythema multiforme is a reaction involving the skin and sometimes the mucosa, triggered by the immune system. Typically, it manifests as target-like lesions, which may appear isolated, recur, or persist. These lesions usually symmetrically affect the extremities, particularly their outer surfaces. The main causes include infections like herpes simplex virus and Mycoplasma pneumoniae, as well as certain medications, immunizations, and autoimmune diseases. Distinguishing erythema multiforme from urticaria relies on the duration of lesions; erythema multiforme lesions remain fixed for at least seven days, while urticarial lesions often vanish within a day. Although similar, it's crucial to differentiate erythema multiforme from the more severe Stevens-Johnson syndrome, which typically presents widespread erythematous or purpuric macules with blisters. Managing erythema multiforme involves symptomatic relief with topical steroids or antihistamines and addressing the underlying cause. For recurrent cases associated with herpes simplex virus, prophylactic antiviral therapy is recommended. Severe mucosal involvement may necessitate hospitalization for intravenous fluids and electrolyte replacement.
Erythema multiforme is a reaction involving the skin and sometimes the mucosa, triggered by the immune system. Typically, it manifests as target-like lesions, which may appear isolated, recur, or persist. These lesions usually symmetrically affect the extremities, particularly their outer surfaces. The main causes include infections like herpes simplex virus and Mycoplasma pneumoniae, as well as certain medications, immunizations, and autoimmune diseases. Distinguishing erythema multiforme from urticaria relies on the duration of lesions; erythema multiforme lesions remain fixed for at least seven days, while urticarial lesions often vanish within a day. Although similar, it's crucial to differentiate erythema multiforme from the more severe Stevens-Johnson syndrome, which typically presents widespread erythematous or purpuric macules with blisters. Managing erythema multiforme involves symptomatic relief with topical steroids or antihistamines and addressing the underlying cause. For recurrent cases associated with herpes simplex virus, prophylactic antiviral therapy is recommended. Severe mucosal involvement may necessitate hospitalization for intravenous fluids and electrolyte replacement.
Conditio variat ex leni, per se, limitata, temeraria ad gravem, vitam minacem, quae nota est erythema multiforme maioris, quod etiam membranas mucosas implicat. Incursio membranae mucosae seu bullae praesentiae signa severitatis momenti sunt.
- Erythema multiforme minor: scuta typica vel elevata, papulae edematoae acrally distributae
Forma lenis solet cum scabie leniter (sed pruritus valde vehemens), maculis roseo-rubentibus, aequaliter dispositis et ab extremitatibus incipiens. Resolutio temeritatis intra 7-10 dies est norma in hac forma morbi.
- Erythema multiforme major: scuta typica vel elevata, papula edemata accraliter distributa cum scrupulo unius vel plurium membranarum mucosarum. Pars epidermalis involvit minus quam 10% totius corporis superficiei.
○ Curatio OTC Medicamenta
Si cum febre (corporis temperatura surgentis), commendatur ut quam primum nosocomium visitet.
Suspecta medicamenta intermitti debent. (v.g. antibiotica, anti-inflammatio medicamentorum nonsteroidalium)
Oral antihistamines ut cetirizine et loratadine ad pruritum.
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]
#Loratadine [Claritin]